Navigate to
-
AMCP 2026 spotlighted oncology innovation, AI, and payer strategies, with KOL insights on cost, access, and evolving managed care trends.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: In the News -
Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
$3,413 Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing strategies, for all lines of business. When...
-
Connect care for your members with cancer Home Our solutions Specialty drug management IntegratedRx IntegratedRx - Oncology Reducing the risk of major side effects IntegratedRx® streamlines the...
-
Insert Link Explore Medical Pharmacy Solutions Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing...
-
IntegratedRx – Cystic Fibrosis drives $28,200 in savings annually per utilizing member.¹ Provider has minimal connection to central specialty pharmacy. Footnotes 1 Based on actual claims,...
-
Discover our value-based contracting solution Support your members with hemophilia We deliver the insights you need on member adherence, program performance and much more with our robust reporting...
-
IntegratedRx®– Cystic Fibrosis streamlines the cystic fibrosis treatment pathway with in-house dispensing and a coordinated care team. Oncology Integration is key Connected physician, member and...
-
April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth leading cause of cancer related death.¹ In 2023, approximately 64,050 people were...
-
Concerns about pricing remain prominent, reflecting the continued introduction of high‑cost agents and the expansion of existing therapies into earlier lines of treatment and longer durations of...